D.A. Davidson & Co. Guardant Health, Inc. Transaction History

D.A. Davidson & Co.

$13.8 Billion
Q2 2025

A detailed history of D.A. Davidson & Co. transactions in Guardant Health, Inc. stock. As of the latest transaction made, D.A. Davidson & Co. holds 39,313 shares of GH stock, worth $1.75 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

39,313

Previous 23,669 66.09%

Holding current value

$1.75 Million

Previous $1.01 Million 102.88%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 30, 2025	BUY	$37.05 - $52.04 $579,610 - $814,113	15,644 Added 66.09%	39,313 $2.05 Million
Q1 2025 Apr 28, 2025	SELL	$31.77 - $49.94 $594,448 - $934,427	-18,711 Reduced 44.15%	23,669 $1.01 Million
Q4 2024 Jan 31, 2025	BUY	$20.2 - $38.11 $358,651 - $676,643	17,755 Added 72.1%	42,380 $1.29 Million
Q3 2024 Nov 13, 2024	SELL	$22.3 - $36.29 $42,816 - $69,676	-1,920 Reduced 7.23%	24,625 $564,000
Q2 2024 Jul 31, 2024	SELL	$16.07 - $31.84 $18,480 - $36,616	-1,150 Reduced 4.15%	26,545 $766,000
Q1 2024 May 13, 2024	SELL	$17.13 - $26.91 $35,938 - $56,457	-2,098 Reduced 7.04%	27,695 $571,000
Q4 2023 Feb 09, 2024	BUY	$21.58 - $29.5 $120,157 - $164,256	5,568 Added 22.98%	29,793 $805,000
Q3 2023 Nov 08, 2023	BUY	$25.8 - $39.97 $67,854 - $105,121	2,630 Added 12.18%	24,225 $718,000
Q2 2023 Aug 10, 2023	BUY	$20.94 - $38.01 $218,320 - $396,292	10,426 Added 93.35%	21,595 $773,000
Q1 2023 Apr 25, 2023	BUY	$22.92 - $33.76 $255,993 - $377,065	11,169 New	11,169 $261,000
Q3 2022 Nov 07, 2022	BUY	$43.66 - $61.0 $33,356 - $46,604	764 Added 12.43%	6,908 $372,000
Q2 2022 Jul 28, 2022	BUY	$28.82 - $77.35 $10,490 - $28,155	364 Added 6.3%	6,144 $248,000
Q1 2022 May 12, 2022	BUY	$48.25 - $100.49 $29,046 - $60,494	602 Added 11.63%	5,780 $383,000
Q4 2021 Jan 31, 2022	BUY	$88.71 - $120.43 $28,209 - $38,296	318 Added 6.54%	5,178 $518,000
Q3 2021 Nov 15, 2021	BUY	$98.77 - $132.17 $34,371 - $45,995	348 Added 7.71%	4,860 $608,000
Q2 2021 Aug 10, 2021	BUY	$109.77 - $165.68 $26,344 - $39,763	240 Added 5.62%	4,512 $560,000
Q1 2021 May 07, 2021	BUY	$127.04 - $179.1 $76,351 - $107,639	601 Added 16.37%	4,272 $652,000
Q4 2020 Feb 10, 2021	BUY	$99.96 - $135.93 $76,769 - $104,394	768 Added 26.46%	3,671 $473,000
Q3 2020 Nov 02, 2020	BUY	$80.32 - $111.8 $21,445 - $29,850	267 Added 10.13%	2,903 $324,000
Q2 2020 Aug 10, 2020	BUY	$60.49 - $97.5 $159,451 - $257,010	2,636 New	2,636 $214,000

Others Institutions Holding GH

# of Institutions

398

Shares Held

123M

Call Options Held

1.43M

Put Options Held

2.35M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.56B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account